Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-02 | 75166 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-05-08 | 2019-05-10 | 83440 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-07-16 | 2020-01-24 | 89482 |
| AVALIDE | 12.5MG 300MG | TABLET | Avoided shortage | 2022-04-14 | 2022-08-11 | 158890 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2022-08-11 | 2022-08-11 | 166530 |
| IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2018-11-12 | 2018-12-29 | 66698 |
| IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2019-04-22 | 2019-06-22 | 82135 |
| SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2019-03-05 | 2020-07-20 | 77655 |
| SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2019-04-01 | 2020-06-22 | 80194 |
| SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2023-03-06 | 2023-03-28 | 186285 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| TARO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80025 |